Nazareno Paolocci, MD, PhD Assistant Professor of Medicine.
Dr. Paolocci graduated (summa cum laude) in Medicine & Surgery from the University of Perugia (Italy) in 1987. After serving as a physician-on-call for underserved areas and 2 years residency in Clinical Pathology, he entered the PhD Program in Neurobiology (University of Perugia), degree obtained in 1994. In November 1997, he joined Johns Hopkins Cardiology to work under the mentorship of Dr. David A. Kass. Dr. Paolocci has been funded continuously by AHA from year 2002 to 2008 and from NIH, from year 2004 until present.
Dr. Paolocci holds several patents for the treatment of congestive heart failure and ischemia-reperfusion injury via nitroxyl donors. He is serving as grant reviewer for American Heart Association (from 2006 to present) and was on NIH study section for 3 years (SBIR Grants). Dr. Paolocci is in the Editorial Board of Cardiovascular Therapeutics and Journal of Pharmacology & experimental Therapeutics and is a member of American Heart Association, American Physiological Society, Biophysical Society, and American Society for Pharmacology and Experimental Therapeutics. Dr. Paolocci is a founder of Cardioxyl Pharmaceuticals, Inc. (MD) whose scope is to develop new HNO donors for the acute treatment of heart failure patients.
Carlo G. Tocchetti, MD, (2002-present)
Grant from the Italian Society of Cardiology (2002-2003)
|Nina Kaludercic, PhD (2006-present)|
|AHA Post-Doc Fellowship (2008-2010)|
|Brian A. Stanley, PhD (2009-present)|
|Sa Shi, PhD (2009-present)|